In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: BioMed X Institute and Merck Successfully Complete Extrachromosomal DNA in Cancer Research Project
BioMed X Institute and Merck Successfully Complete Extrachromosomal DNA in Cancer Research Project
PharmiWeb.com
Visit: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
bioRN
Visit: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
Onco-This-Week
Visit: Daiichi Sankyo gins up antibody research project with German research institute
Daiichi Sankyo gins up antibody research project with German research institute
Fierce Biotech
Visit: BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy
BioMed X Institute launched a new collaboration with Daiichi Sankyo in cancer therapy
Medical Marketing + Media
Visit: BioMed X Institute launches new cancer collaboration with Daiichi Sankyo
BioMed X Institute launches new cancer collaboration with Daiichi Sankyo
bionity.com
Visit: BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy
BioMed X Institute joins forces with Daiichi Sankyo in cancer therapy
The Pharma Letter
Visit: Heidelberger BioMed X kooperiert mit Daiichi
Heidelberger BioMed X kooperiert mit Daiichi
transkript
Visit: Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy
Germany’s BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy
BioSpectrum Asia
Visit: BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment
BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment
Contract Pharma
Visit: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
PharmiWeb.com
Visit: Collaboration targets multi-specific biologics for solid tumour treatment
Collaboration targets multi-specific biologics for solid tumour treatment
Labmate Online
Visit: Daiichi Sankyo gins up antibody research project with German research institute
Daiichi Sankyo gins up antibody research project with German research institute
Fierce Biotech
Visit: Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players
Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players
R&D World
Visit: AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery
AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery
PR Newswire
Visit: New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute
New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute
Pharmiweb
Visit: New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute
New Immuno-Oncology Research Team in Partnership with Ono Pharmaceutical Starts at BioMed X Institute
Yahoo Finance
Visit: BioMed X Start Collaboration in Autoimmunity Research with Servier
BioMed X Start Collaboration in Autoimmunity Research with Servier
BioSpace
Visit: BioMed X Start Collaboration in Autoimmunity Research with Servier
BioMed X Start Collaboration in Autoimmunity Research with Servier
MarketWatch
Visit: BioMed X hilft Boehringer und expandiert in die USA
BioMed X hilft Boehringer und expandiert in die USA
Transkript
Das private Forschungsinstitut BioMed X in Heidelberg meldet erfolgreiche Forschungskooperationen mit der Industrie und expandiert in die USA nach New Haven.
Visit: BioMed X Launches New US Institute in New Haven, CT
BioMed X Launches New US Institute in New Haven, CT
Newsfile
Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.